IVERIC bio Inc (ISEE)
NASDAQ:ISEE

IVERIC bio (ISEE) Stock Price & Analysis

420 Followers

ISEE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$8.85 - $38.25
Previous Close$37.76
Volume1.82M
Average Volume (3M)3.66M
Market Cap
$5.20B
Enterprise Value$4.70B
Total Cash (Recent Filing)$599.95M
Total Debt (Recent Filing)$97.76M
Price to Earnings (P/E)-21.4
Beta1.74
Aug 02, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.76
Shares Outstanding137,782,748
10 Day Avg. Volume3,342,233
30 Day Avg. Volume3,657,003
Standard Deviation0.37
R-Squared0.03
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)11.09
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-25.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-20.50
Forecast
Price Target Upside2.97% Upside
Rating ConsensusHold
Number of Analyst Covering11


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ISEE FAQ

What was IVERIC bio Inc’s price range in the past 12 months?
IVERIC bio Inc lowest stock price was $8.85 and its highest was $38.25 in the past 12 months.
    What is IVERIC bio Inc’s market cap?
    Currently, no data Available
    When is IVERIC bio Inc’s upcoming earnings report date?
    IVERIC bio Inc’s upcoming earnings report date is Aug 02, 2023 which is in 67 days.
      How were IVERIC bio Inc’s earnings last quarter?
      IVERIC bio Inc released its earnings results on May 10, 2023. The company reported -$0.527 earnings per share for the quarter, missing the consensus estimate of -$0.479 by -$0.048.
        Is IVERIC bio Inc overvalued?
        According to Wall Street analysts IVERIC bio Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does IVERIC bio Inc pay dividends?
          IVERIC bio Inc does not currently pay dividends.
          What is IVERIC bio Inc’s EPS estimate?
          IVERIC bio Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does IVERIC bio Inc have?
          IVERIC bio Inc has 137,782,750 shares outstanding.
            What happened to IVERIC bio Inc’s price movement after its last earnings report?
            IVERIC bio Inc reported an EPS of -$0.527 in its last earnings report, missing expectations of -$0.479. Following the earnings report the stock price went down -0.402%.
              Which hedge fund is a major shareholder of IVERIC bio Inc?
              Among the largest hedge funds holding IVERIC bio Inc’s share is Deerfield Management Company, LP. It holds IVERIC bio Inc’s shares valued at 37M.

                ---

                IVERIC bio Stock Smart Score

                The IVERIC bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                IVERIC bio Inc

                IVERIC bio, Inc. is a biopharmaceutical company which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.

                ---

                Top 5 ETFs holding ISEE

                Name
                Market Value
                Smart Score
                Vanguard Health Care ETF
                $13.07M
                8
                Invesco DWA Healthcare Momentum ETF
                $8.44M
                8
                Schwab U.S. Broad Market ETF
                $2.53M
                8
                iShares NASDAQ US Biotechnology UCITS ETF
                $2.41M
                8
                Fidelity MSCI Health Care Index ETF
                $2.24M
                8
                Up to five ETFs with an Outperform Smart Score that hold ISEE. The ETFs are listed according to market value of ISEE within the ETF

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Arrowhead Pharmaceuticals
                Beam Therapeutics
                PTC Therapeutics
                Blueprint Medicines
                Amicus

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis